. Author manuscript; available in PMC: 2011 Apr 1.

Published in final edited form as: J Infect Dis. 2010 Apr 1;201(7):1081–1083. doi: 10.1086/651198

Table 1. Survival of piglets orally-challenged with 1 × 10¹⁰ CFU of EHEC strain 933 and treated IP 48 h after challenge with 2 mg of either Stx2-specific HuMAb 5C12 or Stx1-specific HuMAb 5A4.

Treatment	Total no. of piglets	No. (%) of survivors²	No. (%) died
PBS¹	14	5 (36)	9 (64)
5C12	11	11 (100)	0 (0)
5A4	6	0 (0)	6 (100)

PBS group served as a placebo control.

Survival rates were significantly different (p values: 0.04 for PBS vs 5C12, 0.01 for PBS vs 5A4, and 0.00008 for 5C12 vs 5A4).

Table 1. Survival of piglets orally-challenged with 1 × 1010 CFU of EHEC strain 933 and treated IP 48 h after challenge with 2 mg of either Stx2-specific HuMAb 5C12 or Stx1-specific HuMAb 5A4.